|
1
|
Etienne-Manneville S and Hall A: Rho
GTPases in cell biology. Nature. 420:629–635. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dovas A and Couchman JR: RhoGDI: Multiple
functions in the regulation of Rho family GTPase activities.
Biochem J. 390:1–9. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lelias JM, Adra CN, Wulf GM, Guillemot JC,
Khagad M, Caput D and Lim B: cDNA cloning of a human mRNA
preferentially expressed in hematopoietic cells and with homology
to a GDP-dissociation inhibitor for the rho GTP- binding proteins.
Proc Natl Acad Sci USA. 90:1479–1483. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Scherle P, Behrens T and Staudt LM:
Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding
protein, is expressed preferentially in lymphocytes. Proc Natl Acad
Sci USA. 90:7568–7572. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Leffers H, Nielsen MS, Andersen AH, Honoré
B, Madsen P, Vandekerckhove J and Celis JE: Identification of two
human Rho GDP dissociation inhibitor proteins whose overexpression
leads to disruption of the actin cytoskeleton. Exp Cell Res.
209:165–174. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gildea JJ, Seraj MJ, Oxford G, Harding MA,
Hampton GM, Moskaluk CA, Frierson HF, Conaway MR and Theodorescu D:
RhoGDI2 is an invasion and metastasis suppressor gene in human
cancer. Cancer Res. 62:6418–6423. 2002.PubMed/NCBI
|
|
7
|
Ota T, Maeda M, Suto S and Tatsuka M:
LyGDI functions in cancer metastasis by anchoring Rho proteins to
the cell membrane. Mol Carcinog. 39:206–220. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Seraj MJ, Harding MA, Gildea JJ, Welch DR
and Theodorescu D: The relationship of BRMS1 and RhoGDI2 gene
expression to metastatic potential in lineage related human bladder
cancer cell lines. Clin Exp Metastasis. 18:519–525. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Harding MA and Theodorescu D: RhoGDI
signaling provides targets for cancer therapy. Eur J Cancer.
46:1525–1559. 2010. View Article : Google Scholar
|
|
10
|
Essmann F, Wieder T, Otto A, Müller EC,
Dörken B and Daniel PT: GDP dissociation inhibitor D4-GDI (Rho-GDI
2), but not the homologous rho-GDI 1, is cleaved by caspase-3
during drug-induced apoptosis. Biochem J 346 Pt. 3:777–783. 2000.
View Article : Google Scholar
|
|
11
|
Kettritz R, Xu YX, Faass B, Klein JB,
Müller EC, Otto A, Busjahn A, Luft FC and Haller H:
TNF-alpha-mediated neutrophil apoptosis involves Ly-GDI, a Rho
GTPase regulator. J Leukoc Biol. 68:277–283. 2000.PubMed/NCBI
|
|
12
|
Krieser RJ and Eastman A: Cleavage and
nuclear translocation of the caspase 3 substrate Rho
GDP-dissociation inhibitor, D4-GDI, during apoptosis. Cell Death
Differ. 6:412–419. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Na S, Chuang TH, Cunningham A, Turi TG,
Hanke JH, Bokoch GM and Danley DE: D4-GDI, a substrate of CPP32, is
proteolyzed during Fas-induced apoptosis. J Biol Chem.
271:11209–11213. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rickers A, Brockstedt E, Mapara MY, Otto
A, Dörken B and Bommert K: Inhibition of CPP32 blocks surface
IgM-mediated apoptosis and D4-GDI cleavage in human BL60 Burkitt
lymphoma cells. Eur J Immunol. 28:296–304. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Thiede B, Siejak F, Dimmler C and Rudel T:
Prediction of translocation and cleavage of heterogeneous
ribonuclear proteins and Rho guanine nucleotide dissociation
inhibitor 2 during apoptosis by subcellular proteome analysis.
Proteomics. 2:996–1006. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou X, Suto S, Ota T and Tatsuka M:
Nuclear Translocation of Cleaved LyGDI dissociated from Rho and Rac
during Trp53-dependent ionizing radiation-induced apoptosis of
thymus cells in vitro. Radiat Res. 162:287–295. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Choi MR, Groot M and Drexler HC:
Functional implications of caspase-mediated RhoGDI2 processing
during apoptosis of HL60 and K562 leukemia cells. Apoptosis.
12:2025–2035. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shalini S, Dorstyn L, Dawar S and Kumar S:
Old, new and emerging functions of caspases. Cell Death Differ.
22:526–539. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sordet O, Rébè C, Plenchette S, Zermati Y,
Hermine O, Vainchenker W, Garrido C, Solary E and Dubrez-Daloz L:
Specific involvement of caspases in the differentiation of
monocytes into macrophages. Blood. 100:4446–4453. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liao HS, Matsumoto A, Itakura H, Pittman
T, Kodama T and Geng YJ: De novo expression of the class-A
macrophage scavenger receptor conferring resistance to apoptosis in
differentiated human THP-1 monocytic cells. Cell Death Differ.
6:245–255. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Daigneault M, Preston JA, Marriott HM,
Whyte MK and Dockrell DH: The Identification of Markers of
Macrophage differentiation in PMA-stimulated THP-1 cells and
monocyte-derived macrophages. PLoS One. 5:e86682010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schwende H, Fitzke E, Ambs P and Dieter P:
Differences in the state of differentiation of THP-1 cells induced
by phorbol ester and 1,25-dihydroxyvitamin D3. J Leukoc Biol.
59:555–561. 1996.PubMed/NCBI
|
|
23
|
Auwerx J: The human leukemia cell line,
THP-1: A multifacetted model for the study of monocyte-macrophage
differentiation. Experientia. 47:22–31. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vicca S, Hennequin C, Nguyen-Khoa T, Massy
ZA, Descamps-Latscha B, Drueke TB and Lacour B: Caspase-dependent
apoptosis in THP-1 cells exposed to oxidized low-density
lipoproteins. Biochem Biophys Res Commun. 273:948–954. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Griner EM and Theodorescu D: The faces and
friends of RhoGDI2. Cancer Metastasis Rev. 31:519–528. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang YS, Maeda M, Okamoto M, Fujii M,
Fukutomi R, Hori M, Tatsuka M and Ota T: Centrosomal localization
of RhoGDIβ and its relevance to mitotic processes in cancer cells.
Int J Oncol. 42:460–468. 2013.PubMed/NCBI
|
|
27
|
Ota T, Maeda M, Murakami M, Takegami T,
Suto S and Tatsuka M: Activation of Rac1 by Rho-guanine nucleotide
dissociation inhibitor-beta with defective isoprenyl-binding
pocket. Cell Biol Int. 31:92–96. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ota T, Maeda M, Sakita-Suto S, Zhou X,
Murakami M, Takegami T and Tatsuka M: RhoGDIbeta lacking the
N-terminal regulatory domain suppresses metastasis by promoting
anoikis in v-src-transformed cells. Clin Exp Metastasis.
23:323–334. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen K, Zhao H, Hu Z, Wang LE, Zhang W,
Sturgis EM and Wei Q: CASP3 polymorphisms and risk of squamous cell
carcinoma of the head and neck. Clin Cancer Res. 14:6343–6349.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu HL, Xu WH, Cai Q, Feng M, Long J, Zheng
W, Xiang YB and Shu XO: Polymorphisms and haplotypes in the
caspase-3, caspase-7, and caspase-8 genes and risk for endometrial
cancer: A population-based, case-control study in a Chinese
population. Cancer Epidemiol Biomarkers Prev. 18:2114–2122. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jang JS, Kim KM, Choi JE, Cha SI, Kim CH,
Lee WK, Kam S, Jung TH and Park JY: Identification of polymorphisms
in the Caspase-3 gene and their association with lung cancer risk.
Mol Carcinog. 47:383–390. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gosser YQ, Nomanbhoy TK, Aghazadeh B,
Manor D, Combs C, Cerione RA and Rosen MK: C-terminal binding
domain of Rho GDP-dissociation inhibitor directs N-terminal
inhibitory peptide to GTPases. Nature. 387:814–819. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Platko JV, Leonard DA, Adra CN, Shaw RJ,
Cerione RA and Lim B: A single residue can modify target-binding
affinity and activity of the functional domain of the Rho-subfamily
GDP dissociation inhibitors. Proc Natl Acad Sci USA. 92:2974–2978.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Golovanov AP, Chuang TH, DerMardirossian
C, Barsukov I, Hawkins D, Badii R, Bokoch GM, Lian LY and Roberts
GC: Structure-activity relationships in flexible protein domains:
Regulation of rho GTPases by RhoGDI and D4 GDI. J Mol Biol.
305:121–135. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ota T, Maeda M, Okamoto M and Tatsuka M:
Positive regulation of Rho GTPase activity by RhoGDIs as a result
of their direct interaction with GAPs. BMC Syst Biol. 9:32015.
View Article : Google Scholar : PubMed/NCBI
|
